Recommendations on the statistical analysis of the Comet assay

Pharmaceutical Statistics

Volumn 10, Issue 6, 2011, Pages 485-493

  Bright, Jonathan ^a   Aylott, Mike ^b   Bate, Simon ^c   Geys, Helena ^d   Jarvis, Philip ^a   Saul, Jim ^e   Vonk, Richardus ^f  

^a ASTRAZENECA   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c HUNTINGDON LIFE SCIENCES   (United Kingdom)

^d JANSSEN RESEARCH FOUNDATION   (Belgium)

^e UK   (United Kingdom)

^f BAYER PHARMA AG   (Germany)

Author keywords

Comet assay; median; mixed model; nested design; summary statistics

Indexed keywords

ARTICLE; COMET ASSAY; DRUG INDUSTRY; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ANIMALS; COMET ASSAY; DRUG INDUSTRY; MODELS, STATISTICAL; RODENTIA;

EID: 84855196376     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.530     Document Type: Article

References (19)

1. ICH M3(R2). Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals, January 2010.
2. ICH S2(R1). Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use, March 2008.
3. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM). Guidance on a Strategy for Genotoxicity Testing of Chemical Substances. (link checked October 2011).
4. Lovell DP, Omori T,. Statistical issues in the use of the comet assay. Mutagenesis 2008; 23: 171-182.
5. Rothfuss A, O'Donovan M, De Boeck M, Brault D, Czich A, Custer L, Hamada S, Plappert-Helbig U, Hayashi M, Howe J, Kraynak AR, van der Leede B, Nakajima M, Priestley C, Thybaud V, Saigo K, Sawant S, Shi J, Storer R, Struwe M, Vock E, Galloway S,. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies. Mutation Research 2010; 702: 40-69.
6. International validation of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens (Version 14.2). (link checked August 2011).
7. Wiklund SJ, Agurell E,. Aspects of design and statistical analysis in the Comet assay. Mutagenesis 2003; 18: 167-175. (Pubitemid 36336534)
8. Smith CC, Adkins DJ, Martin EA, O'Donovan MR,. Recommendations for design of the rat comet assay. Mutagenesis 2008; 23: 233-240.
9. Aylott M, Bate S, Collins S, Jarvis P, Saul J,. Review of the statistical analysis of the dog telemetry study. Pharmaceutical Statistics 2011; 10: 236-249.
10. Williams EJ,. Experimental designs balanced for the estimation of residual effects of treatments. Australian Journal of Scientific Research 1949; 2 (3): 149-168.
11. Burlinson B, Tice RR, Speit G, Agurell E, Brendler-Schwaab SY, Collins AR, Escobar P, Honma M, Kumaravel TS, Nakajima M, Sasaki YF, Thybaud V, Uno Y, Vasquez M, Hartmann A,. Fourth international workgroup on genotoxicity testing: result of the in vivo comet assay workgroup. Mutation Research 2007; 627: 31-35. (Pubitemid 46091764)
12. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaud V, Tice RR,. Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis 2003; 18: 45-51. (Pubitemid 36118820)
13. Collins AR,. The comet assay for DNA damage and repair: principles, applications, and limitations. Molecular Biotechnology 2004; 26: 249-261. (Pubitemid 41490465)
14. Williams DA,. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 1971; 27: 103-117.
15. Williams DA,. The comparison of several dose levels with a zero dose control. Biometrics 1972; 28: 519-531.
16. Jonckheere AR,. A distribution-free k-sample test against ordered alternatives. Biometrics 1954; 41: 133-145.
17. Bretz F, Hothorn LA,. Testing dose-response relationships with a priori unknown possibly nonmonotone shapes. Journal of Biopharmaceutical Statistics 2001; 11: 193-207. (Pubitemid 33062688)
18. Dunnett CW,. A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association 1955; 50: 1096-1121.
19. Hayashi M, Dearfield K, Kasper P, Lovell D, Martus H, Thybaud V,. Compilation and use of genetic toxicity historical control data. Mutation Research 2011; 723: 87-90.